About the
TRIUMPH-7 Study
You may be able to participate in the TRIUMPH-7 Study if you:
If you are interested in participating, the study healthcare professional and staff will review additional eligibility criteria with you and answer any questions you may have.
Study Overview
You will take your study medicine (either the investigational medicine or the placebo) as a subcutaneous injection (under the skin) once a week for approximately 16 months. The study will last up to about 18 months, including screening and follow-up, and you will have 21 visits (in-person or telehealth) with healthcare professionals and researchers at the study center.